Choledocholithiasis Global Clinical Trials Review, H1, 2015

Choledocholithiasis Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2533CTIDB
  • |
  • Pages: 44
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Choledocholithiasis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Choledocholithiasis Global Clinical Trials Review, H1, 2015" provides data on the Choledocholithiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Choledocholithiasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Choledocholithiasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Introduction 4

Choledocholithiasis 4

Report Guidance 4

Clinical Trials by Region 5

Clinical Trials and Average Enrollment by Country 6

Top Countries Contributing to Clinical Trials in Asia-Pacific 8

Top Countries Contributing to Clinical Trials in Europe 9

Top Countries Contributing to Clinical Trials in North America 10

Top Countries Contributing to Clinical Trials in Middle East and Africa 11

Clinical Trials by G7 Countries: Proportion of Choledocholithiasis to Gastrointestinal Clinical Trials 12

Clinical Trials in G7 Countries by Trial Status 13

Clinical Trials by Trial Status 14

Clinical Trials by End Point Status 15

Unaccomplished Trials of Choledocholithiasis 16

Subjects Recruited Over a Period of Time 18

Clinical Trials by Sponsor Type 19

Clinical Trial Overview of Top Institutes / Government 20

Sydney West Area Health Service 20

Clinical Trial Overview of Sydney West Area Health Service 20

Kyungpook National University 21

Clinical Trial Overview of Kyungpook National University 21

Arak University of Medical Sciences 22

Clinical Trial Overview of Arak University of Medical Sciences 22

North Bristol NHS Trust 23

Clinical Trial Overview of North Bristol NHS Trust 23

National University Hospital 24

Clinical Trial Overview of National University Hospital 24

National Taiwan University Hospital 25

Clinical Trial Overview of National Taiwan University Hospital 25

University of Thessaly 26

Clinical Trial Overview of University of Thessaly 26

Weill Cornell Medical College 27

Clinical Trial Overview of Weill Cornell Medical College 27

Stanford University 28

Clinical Trial Overview of Stanford University 28

University of Florida 29

Clinical Trial Overview of University of Florida 29

Five Key Clinical Profiles 30

Appendix 42

Abbreviations 42

Definitions 42

Research Methodology 43

Secondary Research 43

About GlobalData 44

Contact Us 44

Disclaimer 44

Source 44

List of Figures

Choledocholithiasis Therapeutics, Global, Clinical Trials by Region (%), 2015* 5

Choledocholithiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6

Choledocholithiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7

Choledocholithiasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 8

Proportion of Choledocholithiasis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 12

Choledocholithiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 13

Choledocholithiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 14

Choledocholithiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 15

Choledocholithiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 18

Choledocholithiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 19

GlobalData Methodology 43

List of Tables

Choledocholithiasis Therapeutics, Global, Clinical Trials by Region, 2015* 5

Choledocholithiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6

Choledocholithiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7

Choledocholithiasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 8

Choledocholithiasis Therapeutics Clinical Trials, Europe, Top Countries, 2015* 9

Choledocholithiasis Therapeutics Clinical Trials, North America, Top Countries, 2015* 10

Choledocholithiasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 11

Proportion of Choledocholithiasis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 12

Choledocholithiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 13

Choledocholithiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 14

Choledocholithiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 15

Choledocholithiasis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 16

Choledocholithiasis Therapeutics, Global, Terminated Clinical Trials, 2015* 17

Choledocholithiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 18

Choledocholithiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 19

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sydney West Area Health Service, 2015* 20

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyungpook National University, 2015* 21

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2015* 22

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by North Bristol NHS Trust, 2015* 23

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National University Hospital, 2015* 24

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015* 25

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Thessaly, 2015* 26

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2015* 27

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2015* 28

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2015* 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Choledocholithiasis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Choledocholithiasis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 161950
Site License
USD 5000 INR 323900
Corporate User License
USD 7500 INR 485850

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com